6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data